William Greenhalf

9PUBLICATIONS
104CO-AUTHORS
Medical virologyPredictive and prognostic markersPharmaceutical delivery technologiesMolecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 16, 2026
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.

|Mar 30, 2026
A Comprehensive Assessment of the Causal Relationship between Atopic Conditions and Pancreatic Cancer Risk: A Two-Sample Mendelian Randomization Study.

Jiangchuan He, Sergio Sabroso-Lasa, Claudia Coscia

|Mar 18, 2026
Optimal Dose and Safety of Intravenous Favipiravir in Hospitalized Patients With COVID-19: A Dose-Escalating, Randomized Controlled Phase Ib Study.

Tim Rowland, Richard FitzGerald, Elizabeth Challenger

|Mar 28, 2023
Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation.

Robert Ferguson, Karen Aughton, Anthony Evans

|Nov 27, 2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA.

Karen Aughton, Nils O Elander, Anthony Evans

|Sep 16, 2021
Genetic Polymorphisms Involved in Mitochondrial Metabolism and Pancreatic Cancer Risk.

Giulia Peduzzi, Manuel Gentiluomo, Francesca Tavano

Pageof 2

Frequent Collaborators

4 joint publications

Eithne Costello

3 joint publications

Anthony Evans

3 joint publications

Rita T Lawlor

3 joint publications

Nuria Malats